An age-old paradigm challenged: Old baboons generate vigorous humoral immune responses to LcrV, a plague antigen

Journal of Immunology

Volumn 181, Issue 1, 2008, Pages 109-115

  Stacy, Sue ^a,b   Pasquali, Amanda ^a   Sexton, Valerie L ^a   Cantwell, Angelene M ^a   Kraig, Ellen ^a,b   Dube, Peter H ^a,b  

^a Department of Cellular and Structural Biology ^*

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; LCRV ANTIGEN; UNCLASSIFIED DRUG; ANTIBODY; LCRV PROTEIN, YERSINIA; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEIN;

AGING; ANIMAL EXPERIMENT; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BABOON; HUMORAL IMMUNITY; IMMUNIZATION; IMMUNOCOMPETENCE; NONHUMAN; PLAGUE; PRIMARY IMMUNE RESPONSE; PRIORITY JOURNAL; SECONDARY IMMUNE RESPONSE; SENESCENCE; YERSINIA PESTIS; ANIMAL; ANTIBODY PRODUCTION; CHIMERA; IMMUNOLOGY; MOUSE; PAPIO;

AGING; ANIMALS; ANTIBODIES; ANTIBODY FORMATION; ANTIGENS, BACTERIAL; CHIMERISM; MICE; PAPIO; PLAGUE VACCINE; PORE FORMING CYTOTOXIC PROTEINS; YERSINIA PESTIS;

EID: 47949099639     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.181.1.109     Document Type: Article

References (44)

1. Gavazzi, G., and K.-H. Krause. 2002. Ageing and infection. Lancet Infect. Dis. 2: 659-666.
2. Ginaldi, L., M. F. Loreto, M. P. Corsi, M. Modesti, and M. De Martinis. 2001. Immunosenescence and infectious diseases. Microbes Infect. 3: 851-857.
3. Webster, R. G. 2000. Immunity to influenza in the elderly. Vaccine 18: 1686-1689.
4. Hakim, F. T., F. A. Flomerfelt, M. Boyiadzis, and R. E. Gress. 2004. Aging, immunity, and cancer. Curr. Opin. Immunol. 16: 151-156.
5. Oxman, M. N., M. J. Levin, J., G. R. Johnson, K. E. Schmader, S. E. Straus, L. D. Gelb, R. D. Arbeit, M. S. Simberkoff, A. A. Gershon, L. E. Davis, et al. 2005. A vaccine to prevent herpes zoster and postherpetic neuralgia in older adults. N. Engl. J. Med. 352: 2271-2284.
6. Vu, T., S. Farish, M. Jenkins, and H. Kelly. 2002. A meta-analysis of effectiveness of influenza vaccine in persons aged 65 years and over living in the community. Vaccine 20: 1831-1836.
7. Hainz, U., B. Jenewein, E. Asch, K. P. Pfeiffer, P. Berger, and B. Grubeck-Loebenstein. 2005. Insufficient protection for healthy elderly adults by tetanus and TBE vaccines. Vaccine 23: 3232-3235.
8. Jefferson, T., D. Rivetti, A. Rivetti, M. Rudin, C. Di Pietrantonj, and V. Demichelli. 2005. Efficacy and effectiveness of influenza vaccines in elderly people: a systematic review. Lancet 366: 1165-1174.
9. de Bruijn, I. A., E. J. Remarque, W. E. Beyer, S. le Cessie, N. Masurel, and G. J. Ligthart. 1997. Annually repeated influenza vaccination improves humoral responses to several influenza virus strains in healthy elderly. Vaccine 15: 1323-1329.
10. McElhaney, J. E., G. S. Meneilly, K. E. Lechelt, B. L. Beattie, and R. C. Bleackley. 1993. Antibody response to whole-virus and split-virus influenza vaccines in successful aging. Vaccine. 11: 1055-1060.
11. Ben-Yedidia, T., L. Abel, R. Arnon, and A. Globerson. 1998. Efficacy of antiinfluenza peptide vaccine in aged mice. Mech. Ageing Dev. 104: 11-23.
12. Gahring, L. C, and W. O. Weigle. 1990. The effect of aging on the induction of humoral and cellular immunity and tolerance in two long-lived mouse strains. Cell. Immunol. 128: 142-151.
13. Stacy, S., A. J. Infante, K. A. Wall, K. A. Krolick, and E. Kraig. 2003. Recall immune memory: a new tool for generating late onset myasthenia gravis. Mech. Ageing Dev. 124:931-940.
14. Frasca, D., R. L. Riley, and B. B. Blomberg. 2005. Humoral immune response and B-cell functions including immunoglobulin class switch are downregulated in aged mice and humans. Semin. Immunol. 17: 378-384.
15. + T cells. Immunol. Rev. 205: 220-228.
16. Miller, R. A., S. B. Berger, D. T. Burke, A. Galecki, G. G. Garcia, J. M. Harper, and A. A. Sadighi. 2005. T cells in aging mice: genetic, developmental, and biochemical analyses. Immunol. Rev. 205: 94-103.
17. Stacy, S., K. A. Krolick, A. J. Infante, and E. Kraig. 2002. Immunological memory and late onset autoimmunity. Mech. Ageing Dev. 123: 975-985.
18. Sambhara, S., A. Kurichh, R. Miranda, O. James, B. Underdown, M. Klein, J. Tartaglia, and D. Burt. 2001. Severe impairment of primary but not memory responses to influenza viral antigens in aged mice: costimulation in vivo partially reverses impaired primary immune responses. Cell. Immunol. 210: 1-4.
19. Harrod, T., M. Martin, and M. W. Russell. 2001. Long-term persistence and recall of immune responses in aged mice after mucosal immunization. Oral Microbiol. Immunol. 16: 170-177.
20. Kapasi, Z. F., K. Murali-Krishna, M. L. McRae, and R. Ahmed. 2002. Defective generation but normal maintenance of memory T cells in old mice. Eur. J. Immunol. 32: 1567-1573.
21. Kennedy, R. C, M. H. Shearer, and W. Hildebrand. 1997. Nonhuman primate models to evaluate vaccine safety and immunogeneicity. Vaccine 15: 903-908.
22. MacPhail, M., J. H. Schickli, R. S. Tang, J. Kaur, C. Robinson, R. A. M. Fouchier, A. D. M. E. Osterhaus, R. R. Spaete, and A. A. Haller. 2004. Identification of small-animal and primate models for evaluation of vaccine candidates for human metapneumovirus (hMPV) and implications for hMPV vaccine design. J. Gen. Virol. 85: 1655-1663.
23. Jeong, S.-H., M. Qiao, M. Nascimbeni, Z. Hu, B. Rehermann, K. Murthy, and T.J. Liang. 2004. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates. J. Virol. 78: 6995-7003.
24. Wolf, R. F., J. F. Papin, R. Hines-Boykin, M. Chavez-Suarez, G. L. White, M. Sakalian, and D. P. Dittmer. 2006. Baboon model for West Nile virus infection and vaccine evaluation. Virology 355: 44-51.
25. Locher, C. P., S. A. Witt, B. G. Herndier, K. Tenner-Racz, P. Racz, and J. A. Levy. 2001. Baboons as an animal model for human immunodeficiency virus pathogenesis and vaccine development. Immunol. Rev. 183: 127-140.
26. Polack, F. P., S. H. Lee, S. Permar, E. Manyara, H. G. Nousari, Y. Jeng, F. Mustafa, A. Valsamakis, R. J. Actams, H. L. Robinson, and D. E. Griffin. 2000. Successful DNA immunization against measles: neutralizing antibody against either the hemagglutinin or fusion glycoprotein protects rhesus macaques without evidence of atypical measles. Nat. Med. 6: 776-781.
27. Murthy, K. K., M. T. Salas, K. D. Carey, and J. L. Patterson. 2006. Baboon as a nonhuman primate model for vaccine studies. Vaccine 24: 4622-4624.
28. Shearer, M. H., R. D. Dark, J. Chodosh, and R. C. Kennedy. 1999. Comparison and characterization of immunoglobulin G subclasses among primate species. Clin. Diag. Lab. Immunol. 6: 953-958.
29. Attanasio, R., K. M. Brasky, S. H. Robbins, L. Jayashankar, R. J. Nash, and T. M. Butler. 2001. Age related autoantibody production in a nonhuman primate model. Clin. Exp. Immunol. 123: 36-35.
30. Williamson, E. D., H. C. Flick-Smith, C. Lebutt, C. A. Rowland, S. M. Jones, E. L. Waters, R. J. Gwyther, J. Miller. P. J. Packer, and M. Irving. 2005. Human immune response to a plague vaccine comprising recombinant F1 and V antigens. Infect. Immun. 73: 3598-3608.
31. Jones, S. M., F. Day, A. J. Stagg, and E. D. Williamson. 2000. Protection conferred by a fully recombinant sub-unit vaccine against Yersinia pestis in male and female mice of four inbred strains. Vaccine 19: 358-366.
32. Jones, S. M., K. F. Griffin, I. Hodgson, and E. D. Williamson. 2003. Protective efficacy of a fully recombinant plague vaccine in the guinea pig. Vaccine 21: 3912-3918.
33. Galimand, M., A. Guiyoule, G. Gerbaud, B. Rasoamanana, S. Chanteau, E. Carniel, and P. Courvalin. 1997. Multidrug resistance in Yersinia pestis mediated by a transferable plasmid. N. Engl. J. Med. 337: 677-680.
34. Guiyoule, A., G. Gerbaud, C. Buchrieser, M. Galimand, L. Rahalison, S. Chanteau, P. Courvalin, and E. Carniel. 2001. Transferable plasmid-mediated resistance to streptomycin in a clinical isolate of Yersinia pestis. Emerg. Infect. Dis. 7: 43-48.
35. Saikh, K. U., J. Sesno, P. Brandler, and R. G. Ulrich. 1998. Are DNA-bascd vaccines useful for protection against secreted bacterial toxins? Tetanus toxin test case. Vaccine 16: 1029-1038.
36. Williamson, E. D., P. M. Vesey, K. J. Gillhespy, S. M. Eley, M. Green, and R. W. Titball. 1999. An IgG1 litre to the F1 and V antigens correlates with protection against plague in the mouse model. Clin. Exp. Immunol. 116: 107-114.
37. Eto, T., and H. Takahashi. 1999 Enhanced inhibition of hepatitis B virus production by asialoglycoprotein receptor-directed interferon. Nat. Med. 5:577-581.
38. Romero-Steiner, S., D. M. Musher, M. S. Cetron, L. B. Pais, J. E. Groover, A. E. Fiore, B. D. Plikaytis, and G. M. Carlone. 1998. Reduction in functional antibody avidity against Streptococcus pneumoniae in vaccinated elderly individuals highly correlates with decreased IgG antibody avidity. Clin. Infect. Dis. 29: 281-8.
39. Jayashankar, L., K. M. Brasky, J. A. Ward, and R. Attanasio. 2003. Lymphocyte modulation in a baboon model of immunosenescence. Clin. Diag. Lab Immunol. 10: 870-875.
40. Healy, D. L., J. Bacher, and G. D. Hodgen. 1983. A method of thymectomy in macaques monkeys. J. Med. Primatol. 12: 89-100.
41. Ershler, W. B., C. L. Coe, S. Gravenstein, K. T. Schultz, R. G. Klopp, M. Meyer, and W. D. Houser. 1988. Aging and immunity in nonhuman primates: I. Effects of age and gender on cellular immune function in rhesus monkeys (Macaca mulatto) J. Primatol. 15: 181-188.
42. Jankovic, V., I. Messaoudi, and J. Nikolich-Zugich. 2003. Phenotypic and functional T cell aging in rhesus macaques differential behavior of CD4 and CD8 subsets. Blood 102: 3244-3251.
43. Pitcher, C. J., S. I. Hagen, J. M. Walker, R. Lum, B. L. Mitchell, V. C. Maino, M. K. Axthelm, and L. J. Picker. 2002. Development and homeostasis of T cell memory in rhesus macaque. J. Immunol. 168: 29-13.
44. + double positive T lymphocytes in cynomolgus monkeys: longitudinal study in relation to thymic involution. Immunology 109: 217-225.